Press Releases 2017

New data confirms that the Boston Scientific WATCHMAN™ Left Atrial Appendage Closure Device is safe and effective in reducing the risk of stroke in patients deemed unsuitable for oral anticoagulation - May 18, 2017

One-year data from the EWOLUTION registry found that left atrial appendage closure (LAAC) with the WATCHMAN™ device followed by dual antiplatelet therapy (DAPT) significantly ...

Read more

Media Contacts

Rosie Ireland
Corporate Communications
+44 7585403359

Company Profile